Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
The American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), and...
The gene therapy etranacogene dezaparvovec substantially increased production of the blood clotting protein factor IX among 52 patients in the...
Genetic mutations linked with cancer can occur during childhood or even before birth and proliferate in the body for many years before causing cancer ...
In a phase III trial called ASCEMBL, the experimental drug asciminib was nearly twice as effective as a standard-of-care treatment regimen for...
Three studies being presented during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition report promising results in the use...
There are now millions of cases worldwide of COVID-19 infection, caused by the new virus SARS-CoV-2. As cases continue to soar, researchers around...
Four studies being presented during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition present opportunities to improve care ...
Four studies being presented during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition highlight the ways disparities and...
Today, ASH released new guidelines to help clinicians prevent serious blood clotting complications affecting COVID-19 patients. The recommendations...
Across the United States, adults with sickle cell disease (SCD) lack access to comprehensive care to manage their condition, help them prevent...
Today, ASH published new guidelines to help older adults with acute myeloid leukemia (AML) and their health care providers make critical care...
The American Society of Hematology (ASH) congratulates this year's recipients of the Honorific Awards, the Society's most prestigious awards which...
Today, the American Society of Hematology (ASH), the world's largest professional society dedicated to furthering the understanding, diagnosis,...
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced a collaboration with the American...
Coagulopathy, or abnormal blood clotting, has been reported as a complication associated with increased risk of death in patients with COVID-19....
The ASH Research Collaborative (ASH RC) has collaborated with two industry leaders, Novartis Pharmaceuticals Corporation (Novartis) and Amgen, to...
Today, ASH published new state-of-the art guidelines on the treatment of immune thrombocytopenia (ITP), a rare blood disorder characterized by a...
Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to their cancer diagnosis compared with similar...
The editors of Blood, the most-cited journal in hematology, have selected the top manuscripts of 2018. "These 10 publications were chosen from the...
In a first-in-human clinical trial reported today in Blood, the investigational drug sutimlimab appeared to be effective in treating cold agglutinin...
Chimeric antigen receptor (CAR) T-cell therapies have quickly shifted the treatment paradigm for many people with several types of aggressive blood...
Today during the 60th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, presenters of three studies will highlight how ...
Today during the 60th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, researchers will present the results of four...
Today at the 60th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, researchers will announce findings from four...
Researchers have developed a way to grow human platelets in the laboratory from stem cells derived from fat tissue. The achievement, reported today...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.